Altair Therapeutics
150 Spear Street
Suite 1050
San Francisco
California
94105
United States
Tel: 415-541-8600
Fax: 415-541-8980
8 articles about Altair Therapeutics
-
InMed Taps Former Altair Therapeutics Exec as President & CEO
9/3/2015
-
Altair Therapeutics Announces Commencement of a Multi-Center Phase IIa Clinical Trial of Inhaled AIR645 to Treat Asthma
11/19/2009
-
Altair Therapeutics Secures $17 Million Financing
11/12/2009
-
Altair Therapeutics Reports Successful Phase I Study of Inhaled AIR645
9/14/2009
-
Altair Therapeutics Reports Successful Completion of Phase I Study of Inhaled AIR645
5/18/2009
-
Altair Therapeutics Appoints Dr. Joel Martin President and CEO
5/15/2009
-
Forward Ventures Joins Series A Syndicate for Newly Formed Altair Therapeutics
12/18/2007
-
Isis Pharmaceuticals, Inc. and Thomas, McNerney & Partners Announce Plans for Newly Formed Altair Therapeutics
10/16/2007